Altimmune ALT Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Altimmune’s reported figures.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's invested capital?
- Altimmune (ALT) reported invested capital of $221.11M in Q1 2026.
- How has Altimmune's invested capital changed year-over-year?
- Altimmune's invested capital increased by 137.1% year-over-year, from $93.26M to $221.11M.
- What is the long-term trend for Altimmune's invested capital?
- Over 5 years (2020 to 2025), Altimmune's invested capital has grown at a 13.8% compound annual growth rate (CAGR), from $113.58M to $216.78M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).